203 related articles for article (PubMed ID: 32833021)
1. Incidence Trends and Burden of Human Papillomavirus-Associated Cancers Among Women in the United States, 2001-2017.
Deshmukh AA; Suk R; Shiels MS; Damgacioglu H; Lin YY; Stier EA; Nyitray AG; Chiao EY; Nemutlu GS; Chhatwal J; Schmeler K; Sigel K; Sonawane K
J Natl Cancer Inst; 2021 Jun; 113(6):792-796. PubMed ID: 32833021
[TBL] [Abstract][Full Text] [Related]
2. Trends in Human Papillomavirus-Associated Cancers, Demographic Characteristics, and Vaccinations in the US, 2001-2017.
Liao CI; Francoeur AA; Kapp DS; Caesar MAP; Huh WK; Chan JK
JAMA Netw Open; 2022 Mar; 5(3):e222530. PubMed ID: 35294540
[TBL] [Abstract][Full Text] [Related]
3. Clinical and economic burden of HPV-related cancers in the US veteran population.
Saxena K; Dawson RS; Cyhaniuk A; Bello T; Janjan N
J Med Econ; 2022; 25(1):299-308. PubMed ID: 35156867
[TBL] [Abstract][Full Text] [Related]
4. HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women.
Gillison ML; Chaturvedi AK; Lowy DR
Cancer; 2008 Nov; 113(10 Suppl):3036-46. PubMed ID: 18980286
[TBL] [Abstract][Full Text] [Related]
5. Vulvar Cancer Incidence in the United States and its Relationship to Human Papillomavirus Vaccinations, 2001-2018.
Berenson AB; Chang M; Hawk ET; Ramondetta LM; Hoang T
Cancer Prev Res (Phila); 2022 Nov; 15(11):777-784. PubMed ID: 35969832
[TBL] [Abstract][Full Text] [Related]
6. Beyond cervical cancer: burden of other HPV-related cancers among men and women.
Chaturvedi AK
J Adolesc Health; 2010 Apr; 46(4 Suppl):S20-6. PubMed ID: 20307840
[TBL] [Abstract][Full Text] [Related]
7. Temporal Trends and Projection of Cancer Attributable to Human Papillomavirus Infection in China, 2007-2030.
Duan R; Xu K; Huang L; Yuan M; Wang H; Qiao Y; Zhao F
Cancer Epidemiol Biomarkers Prev; 2022 May; 31(5):1130-1136. PubMed ID: 35266990
[TBL] [Abstract][Full Text] [Related]
8. Risk of human papillomavirus-associated cancers among persons with AIDS.
Chaturvedi AK; Madeleine MM; Biggar RJ; Engels EA
J Natl Cancer Inst; 2009 Aug; 101(16):1120-30. PubMed ID: 19648510
[TBL] [Abstract][Full Text] [Related]
9. Cancer burden attributable to human papillomavirus infection by sex, cancer site, age, and geographical area in China.
Duan R; Qiao Y; Clifford G; Zhao F
Cancer Med; 2020 Jan; 9(1):374-384. PubMed ID: 31714036
[TBL] [Abstract][Full Text] [Related]
10. Prevention and Screening of HPV Malignancies.
Dahlstrom KR; Day AT; Sturgis EM
Semin Radiat Oncol; 2021 Oct; 31(4):297-308. PubMed ID: 34455985
[TBL] [Abstract][Full Text] [Related]
11. HPV-Related Cancers: A Growing Threat to U.S. Military Health and Readiness.
Seay J; Matsuno R; Buechel J; Tannenbaum K; Wells N
Mil Med; 2022 May; 187(5-6):149-154. PubMed ID: 34697641
[TBL] [Abstract][Full Text] [Related]
12. Trends in the Incidence of Human Papillomavirus-Associated Cancers by County-Level Income and Smoking Prevalence in the United States, 2000-2018.
Lin YY; Damgacioglu H; Suk R; Wu CF; Zhu Y; Ortiz AP; Hara SK; Sonawane K; Deshmukh AA
JNCI Cancer Spectr; 2022 Mar; 6(2):. PubMed ID: 35603851
[TBL] [Abstract][Full Text] [Related]
13. Update of HPV-associated female genital cancers in the United States, 1999-2004.
Watson M; Saraiya M; Wu X
J Womens Health (Larchmt); 2009 Nov; 18(11):1731-8. PubMed ID: 19951205
[TBL] [Abstract][Full Text] [Related]
14. Trends in HPV- and non-HPV-associated vulvar cancer incidence, United States, 2001-2017.
Mix JM; Gopalani SV; Simko S; Saraiya M
Prev Med; 2022 Nov; 164():107302. PubMed ID: 36240909
[TBL] [Abstract][Full Text] [Related]
15. The burden of human papillomavirus infections and related diseases in sub-saharan Africa.
De Vuyst H; Alemany L; Lacey C; Chibwesha CJ; Sahasrabuddhe V; Banura C; Denny L; Parham GP
Vaccine; 2013 Dec; 31 Suppl 5(0 5):F32-46. PubMed ID: 24331746
[TBL] [Abstract][Full Text] [Related]
16. US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines.
Saraiya M; Unger ER; Thompson TD; Lynch CF; Hernandez BY; Lyu CW; Steinau M; Watson M; Wilkinson EJ; Hopenhayn C; Copeland G; Cozen W; Peters ES; Huang Y; Saber MS; Altekruse S; Goodman MT;
J Natl Cancer Inst; 2015 Jun; 107(6):djv086. PubMed ID: 25925419
[TBL] [Abstract][Full Text] [Related]
17. Trends in Risks for Second Primary Cancers Associated With Index Human Papillomavirus-Associated Cancers.
Suk R; Mahale P; Sonawane K; Sikora AG; Chhatwal J; Schmeler KM; Sigel K; Cantor SB; Chiao EY; Deshmukh AA
JAMA Netw Open; 2018 Sep; 1(5):e181999. PubMed ID: 30646145
[TBL] [Abstract][Full Text] [Related]
18. Estimated Prevalence and Incidence of Disease-Associated Human Papillomavirus Types Among 15- to 59-Year-Olds in the United States.
Lewis RM; Laprise JF; Gargano JW; Unger ER; Querec TD; Chesson HW; Brisson M; Markowitz LE
Sex Transm Dis; 2021 Apr; 48(4):273-277. PubMed ID: 33492097
[TBL] [Abstract][Full Text] [Related]
19. Cancer attributable to human papillomavirus infection in China: Burden and trends.
Lu Y; Li P; Luo G; Liu D; Zou H
Cancer; 2020 Aug; 126(16):3719-3732. PubMed ID: 32484937
[TBL] [Abstract][Full Text] [Related]
20. Burden of Human papillomavirus (HPV)-related disease and potential impact of HPV vaccines in the Republic of Korea.
Kim YT; Serrano B; Lee JK; Lee H; Lee SW; Freeman C; Oh JK; Alemany L; Bosch FX; Bruni L
Papillomavirus Res; 2019 Jun; 7():26-42. PubMed ID: 30599280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
